These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2929 related articles for article (PubMed ID: 18425107)

  • 1. Functions of natural killer cells.
    Vivier E; Tomasello E; Baratin M; Walzer T; Ugolini S
    Nat Immunol; 2008 May; 9(5):503-10. PubMed ID: 18425107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
    Borg C; Taieb J; Terme M; Maruyama K; Flament C; Angevin E; Zitvogel L
    Bull Cancer; 2003; 90(8-9):699-705. PubMed ID: 14609759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections.
    Terunuma H; Deng X; Dewan Z; Fujimoto S; Yamamoto N
    Int Rev Immunol; 2008; 27(3):93-110. PubMed ID: 18437601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer (NK) cells and their possible roles in resistance against disease.
    Herberman RB
    Clin Immunol Rev; 1981; 1(1):1-65. PubMed ID: 6219848
    [No Abstract]   [Full Text] [Related]  

  • 5. Natural killer cells in human autoimmunity.
    Flodström-Tullberg M; Bryceson YT; Shi FD; Höglund P; Ljunggren HG
    Curr Opin Immunol; 2009 Dec; 21(6):634-40. PubMed ID: 19892538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications of adoptive natural killer cell immunotherapy for cancer: current status and future prospects.
    Guo H; Qian X
    Onkologie; 2010; 33(7):389-95. PubMed ID: 20631487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-host immune interactions and dendritic cell dysfunction.
    Yang L; Carbone DP
    Adv Cancer Res; 2004; 92():13-27. PubMed ID: 15530555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell tolerance licensing and other mechanisms.
    Jonsson AH; Yokoyama WM
    Adv Immunol; 2009; 101():27-79. PubMed ID: 19231592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cell-directed therapies: moving from unexpected results to successful strategies.
    Terme M; Ullrich E; Delahaye NF; Chaput N; Zitvogel L
    Nat Immunol; 2008 May; 9(5):486-94. PubMed ID: 18425105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invariant NKT cells and tolerance.
    Nowak M; Stein-Streilein J
    Int Rev Immunol; 2007; 26(1-2):95-119. PubMed ID: 17454266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.
    Fujii S
    Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal regulation between natural killer cells and autoreactive T cells.
    Shi FD; Van Kaer L
    Nat Rev Immunol; 2006 Oct; 6(10):751-60. PubMed ID: 16998508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-directional cross-regulation of NK cell function during innate immune responses.
    Marcenaro E; Dondero A; Moretta A
    Transpl Immunol; 2006 Dec; 17(1):16-9. PubMed ID: 17157207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined cell therapy by using dendritic cells, T-cells and NK cells to human polymorphic cancer].
    Matsushita N; Kobayashi Y; Tanaka Y; Nakao M; Shimizu K; Takeshita N; Tanigawa K; Aruga A
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1655-8. PubMed ID: 15553674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta and the immune response: implications for anticancer therapy.
    Wrzesinski SH; Wan YY; Flavell RA
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5262-70. PubMed ID: 17875754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).
    Hoskin DW; Mader JS; Furlong SJ; Conrad DM; Blay J
    Int J Oncol; 2008 Mar; 32(3):527-35. PubMed ID: 18292929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cells in innate immunity.
    Hamerman JA; Ogasawara K; Lanier LL
    Curr Opin Immunol; 2005 Feb; 17(1):29-35. PubMed ID: 15653307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK cells: new issues and challenges. Preface.
    Colonna M
    Eur J Immunol; 2008 Nov; 38(11):2927-9. PubMed ID: 18979520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine organs under the control of the immune system: potential implications for cellular therapies.
    Jacobs B; Papewalis C; Ehlers M; Schott M
    Horm Metab Res; 2010 Dec; 42(13):912-7. PubMed ID: 21132622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells: the journey from puzzles in biology to treatment of cancer.
    Bodduluru LN; Kasala ER; Madhana RM; Sriram CS
    Cancer Lett; 2015 Feb; 357(2):454-67. PubMed ID: 25511743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 147.